In-vitro fertilization (IVF) Market By Types of cycle (Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor), Donor Egg IVF Cycle) By Application (Fertility Clinics, Hospitals, Surgical Centers) - Global Size Analysis and Industry Forecast, 2018-2023

Global In-vitro fertilization (IVF) Market was valued at USD 507.98 Million in the year 2017. Global In-vitro fertilization (IVF) Market is further estimated to grow at a CAGR of 10.41 % from 2018 to reach USD 920 Million by the year 2023. North America region holds the highest market share in 2017 and Europe is considered as the fastest growing market in the forecasted period. At country level, developed markets U.S holds a substantial market share in 2017 and it is projected to grow at a gradual pace in the coming years.

Get Free Access to Sample Report @ https://genesismarketinsights.com/Sample_Request/GENRE205

OvaScience (U.S), EMD Serono, Inc. (U.S), Irvine Scientific (U.S), CooperSurgical, Inc. (U.S) and Vitrolife AB (Sweden) are some of the key players in the In-vitro fertilization (IVF) Market. Rising research and development expenses to address the changing demand of end users, similarly growth strategies such as acquisition, merger and expansion of the distribution network were few techniques adopted by most of the top players in the last 5 years.

Get Full Customized Report @ https://genesismarketinsights.com/Report_Enquiry/GENRE205

Drivers:

• Declining fertility rate
• Increasing incidences of male and female infertility

Restraints:

• High Cost and Low Success Rate of the IVF Treatment
• Lack of regulatory framework

Opportunities:

• Availability of supportive government funding
• Fertility Tourism

Challenges:

• Reducing Efficacy of Infertility Treatment with Advancing Age
• Ethical considerations

The global in-vitro fertilization (IVF) market id segmented on the basis of types of cycle, by application and by region. On the basis of types of cycle the market is segmented as Fresh Cycle (Non-Donor), Thawed IVF Cycle (Non-Donor) and Donor Egg IVF Cycle of which Fresh Cycle (Non-Donor) segment is expected to hold the highest market share during the forecast period.

On the basis of application the market is segmented as Fertility Clinics, Hospitals, Surgical Centers and Clinical Research Institutes, in which Fertility Clinics holds the highest market share.

Key Benefits for Stakeholders

• In-vitro fertilization (IVF) Manufacturers, Distributors and Retailers
• Research and Consulting organization
• Healthcare service providers & Vendors
• Healthcare institutions (hospitals, clinics, cryobanks)
• Research institutes

By Types of cycle

• Fresh Cycle (Non-Donor)
• Thawed IVF Cycle (Non-Donor)
• Donor Egg IVF Cycle

By Application

• Fertility Clinics
• Hospitals
• Surgical Centers
• Clinical Research Institutes

By Region

• North America
• Europe
• Asia-Pacific
• RoW

Key Market Players

• OvaScience
• EMD Serono, Inc.
• Irvine Scientific
• CooperSurgical, Inc.
• Vitrolife AB
• Cook Medical, Inc.
• Progyny, Inc.
• Genea Biomedx
• Boston IVF
• Kitazato Corporation

(Another brief information of 15 companies will be provided in report.)

GET 40% DISCOUNT ON FINAL REPORT PRICING FOR THE FIRST TIME BUYER @ https://genesismarketinsights.com/viewreport/206/28/In-Vitro-Fertilization-Market

About Us:

Genesis Market Insights (GMI), is a subsidiary of Genesis Management & Market Research Pvt.Ltd. (GMMR) having a strong experience both in primary and secondary market research serving small to large scale enterprises across globe. Established in 1993, GMMR has become a recommended brand for Market Research for various international and MNC Corporations with its strong data foundation. With its exhaustive research capabilities, strong analytics services and in house data validation tools, GMMR has delivered actionable, reliable and all-inclusive Market Research Reports. GMMR is growing strongly for last 2 decades with most of the clients providing repeat business for their trust on the data quality and recommendations for decision making.

Contact Us;

Genesis Market Insights (GMI)
902 Broadway, 6th Floor,
New York, NY 10010
(212) 634-4560
Mail us at: info@genesismarketinsights.com
Website: www.genesismarketinsights.com

This release was published on openPR.